By Marcus Devlin
Two decades covering equity markets. Writes on single stocks, sectors, valuations and the trades behind the tape.
Seven & i Lifts Profit Forecast as US Gasoline Revenue and Weak Yen Boost Earnings
Seven & i lifted its full-year profit outlook despite a drop in quarterly sales. A 24% net income jump, fueled by US gasoline revenue and a
BofA Upgrades Aena on Strong Passenger Traffic, Sees Q2 Beat Ahead
BofA Global Research upgraded Aena, the Spanish airport operator, after January-May 2026 traffic rose 3.7% year over year. The bank believes
China Stocks Rally as PBoC Pledges Loose Policy Despite Mixed Inflation Signals
Chinese stocks bounced on Tuesday after the central bank reaffirmed its commitment to loose monetary policy. The move came despite mixed Jun
Asian Fund Giants Temasek and Goldman Sachs Get Pickier on AI Bets, Favor Infrastructure
At Reuters NEXT Asia in Singapore, major investors including Temasek and Goldman Sachs Asset Management expressed a more cautious stance on
European Tech Stocks Rebound as Chip Names Rally, STOXX 600 Edges Up 0.4%
European stocks edged higher in choppy trading, led by a 1.6% gain in the tech sector as chip stocks rebounded. The STOXX 600 rose 0.4% to 6
Computacenter Nearly Doubles Profit as AI Data Center Demand Surges
Computacenter expects full-year results to beat market forecasts as demand for AI-ready data center gear boosts profits. First-half adjusted
Workspace Group Urges Shareholders to Reject Saba's Fast-Sale Plan Ahead of AGM
Workspace Group is asking shareholders to vote down Saba Capital's proposals at its July 23rd AGM. The activist investor wants faster proper
Nikkei Rises 1.4% on AI Chip Rally, but Oil Gains Cap Broader Gains
Japan's Nikkei 225 climbed 1.4% as AI chip stocks like Kioxia and Advantest surged, but a 1% oil price jump from US-Iran tensions capped bro
RBC Sees Galderma's Q2 Growth Slowing but Raises Price Target on Long-Term Hopes
RBC Capital Markets forecasts Galderma's Q2 constant-currency sales growth will slow to 18%, near the low end of its guidance. Despite this,
Barry Callebaut Volumes Rise for First Time in Two Years as Cocoa Costs Bite
Barry Callebaut saw its first year-on-year volume increase in two years, with Q3 volumes up 5.7%. The gain came from stabilizing North Ameri
Jefferies Says AI Will Boost Pro Medicus, But Downgrades to Hold on Valuation
Jefferies believes AI will support Pro Medicus' Visage PACS in capturing more US market share, but the bank downgraded the stock to hold. Th
Arbex Aims to Boost Kleenex's Global Market Share to 35% as Standalone Venture
Arbex, the $3.4 billion joint venture behind Kleenex, plans to lift its global tissue market share from about 24-25% to over 35%. The standa